1	Cyclosporin	Cyclosporin	_	_	_	_	_	_	_
2	A-resistant	a-resistant	_	_	_	_	_	_	_
3	transactivation	transactivation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	promoter	promoter	_	_	_	_	_	_	_
8	requires	require	_	_	_	_	_	_	_
9	activity	activity	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	okadaic	okadaic	_	_	_	_	_	_	_
12	acid-sensitive	acid-sensitive	_	_	_	_	_	_	_
13	serine/threonine	serine/threonine	_	_	_	_	_	_	_
14	phosphatases	phosphatas	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	IL-2	il-2	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	requires	require	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	through	through	_	_	_	_	_	_	_
12	stimulation	stimulation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	TCR	TCR	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	costimulation	costimulation	_	_	_	_	_	_	_
18	through	through	_	_	_	_	_	_	_
19	accessory	accessory	_	_	_	_	_	_	_
20	receptors	receptor	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	found	find	_	_	_	_	_	_	_
4	recently	recently	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	okadaic	okadaic	_	_	_	_	_	_	_
7	acid-sensitive	acid-sensitive	_	_	_	_	_	_	_
8	Ser/Thr	Ser/Thr	_	_	_	_	_	_	_
9	phosphatases	phosphatas	_	_	_	_	_	_	_
10	are	be	_	_	_	_	_	_	_
11	involved	involve	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	cyclosporin	cyclosporin	_	_	_	_	_	_	_
15	A-insensitive	a-insensitive	_	_	_	_	_	_	_
16	pathway	pathway	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	selectively	selectively	_	_	_	_	_	_	_
19	transmits	transmit	_	_	_	_	_	_	_
20	costimulatory	costimulatory	_	_	_	_	_	_	_
21	signals	signal	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	analyzed	analyze	_	_	_	_	_	_	_
7	whether	whether	_	_	_	_	_	_	_
8	activities	activity	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	these	these	_	_	_	_	_	_	_
11	phosphatases	phosphatas	_	_	_	_	_	_	_
12	are	be	_	_	_	_	_	_	_
13	necessary	necessary	_	_	_	_	_	_	_
14	for	for	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	expression	expression	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	IL-2	il-2	_	_	_	_	_	_	_
20	gene	gene	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	both	both	_	_	_	_	_	_	_
3	activated	activate	_	_	_	_	_	_	_
4	peripheral	peripheral	_	_	_	_	_	_	_
5	blood	blood	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	activated	activate	_	_	_	_	_	_	_
10	tumorigenic	tumorigenic	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	lines	line	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	IL-2	il-2	_	_	_	_	_	_	_
16	gene	gene	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	blocked	block	_	_	_	_	_	_	_
20	at	at	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	transcriptional	transcriptional	_	_	_	_	_	_	_
23	level	level	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	okadaic	okadaic	_	_	_	_	_	_	_
26	acid	acid	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	factors	factor	_	_	_	_	_	_	_
4	active	active	_	_	_	_	_	_	_
5	at	at	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	promoter	promoter	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	differentially	differentially	_	_	_	_	_	_	_
11	influenced	influence	_	_	_	_	_	_	_
12	:	:	_	_	_	_	_	_	_
13	upon	upon	_	_	_	_	_	_	_
14	down-modulation	down-modulation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	okadaic	okadaic	_	_	_	_	_	_	_
17	acid-sensitive	acid-sensitive	_	_	_	_	_	_	_
18	phosphatases	phosphatas	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	transactivation	transactivation	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	octamer	octamer	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	NF-kappa	NF-kappa	_	_	_	_	_	_	_
25	B	B	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	NF	NF	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	activated	activate	_	_	_	_	_	_	_
31	T	t	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	proteins	protein	_	_	_	_	_	_	_
34	was	be	_	_	_	_	_	_	_
35	abrogated	abrogate	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	while	while	_	_	_	_	_	_	_
38	transactivation	transactivation	_	_	_	_	_	_	_
39	by	by	_	_	_	_	_	_	_
40	AP-1	ap-1	_	_	_	_	_	_	_
41	proteins	protein	_	_	_	_	_	_	_
42	was	be	_	_	_	_	_	_	_
43	even	even	_	_	_	_	_	_	_
44	enhanced	enhance	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

